Sponsor Dossier
Hugel
Sponsor Dossier for Hugel. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: LETYBO
- Device (sponsor): REVOLAX™ FINE with Lidocaine - Synthetic-fluid tissue reconstructive material, anaesthetic
- Device (sponsor): REVOLAX™ SUB-Q with Lidocaine - Synthetic-fluid tissue reconstructive material, anaesthetic
- Device (sponsor): REVOLAX™ DEEP with Lidocaine - Synthetic-fluid tissue reconstructive material, anaesthetic
- Device (sponsor): Princess Volume Lidocaine - Synthetic-fluid tissue reconstructive material, anaesthetic
- Device (sponsor): Princess Filler - Dermal tissue reconstructive material, microbe-derived
- Device (sponsor): Princess Rich - Dermal tissue reconstructive material, microbe-derived
- Device (sponsor): Princess Volume Plus Lidocaine - Synthetic-fluid tissue reconstructive material, anaesthetic
- Device (sponsor): Princess Volume - Dermal tissue reconstructive material, microbe-derived
- Device (sponsor): Princess Filler Lidocaine - Synthetic-fluid tissue reconstructive material, anaesthetic
- Device (sponsor): Cannula, tissue injection
About
Hugel is an Australian Private Company with ABN 93159477988, registered in New South Wales. The entity is active and has traded under the business names HUGEL AESTHETICS and CROMA Australia.
Portfolio
Hugel has 1 brand on the ARTG, of which 1 is indexable and 1 carries a Product Information document. 0 brands are PBS-listed, 0 have a PBAC outcome on record, and 1 has an AusPAR on record. Notable brands include LETYBO.
Therapeutic focus
— Dermatology: 1 brand
Regulatory activity
The latest AusPAR is 2023-11-28, across 1 brand with an AusPAR on record.